It is established that STAG2 acts in a pro-tumorigenic manner in bladder cancer [9, 12, 35], and therefore STAG2 may exert an oncogenic function through regulation of PI3K signaling in bladder cancer cells. This evidence concerns the gene STAG2 and urinary bladder carcinoma.